Correlation Between NewAmsterdam Pharma and Aldeyra

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Aldeyra at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Aldeyra into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Aldeyra, you can compare the effects of market volatilities on NewAmsterdam Pharma and Aldeyra and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Aldeyra. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Aldeyra.

Diversification Opportunities for NewAmsterdam Pharma and Aldeyra

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between NewAmsterdam and Aldeyra is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Aldeyra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aldeyra and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Aldeyra. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aldeyra has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Aldeyra go up and down completely randomly.

Pair Corralation between NewAmsterdam Pharma and Aldeyra

Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 0.67 times more return on investment than Aldeyra. However, NewAmsterdam Pharma is 1.49 times less risky than Aldeyra. It trades about 0.04 of its potential returns per unit of risk. Aldeyra is currently generating about 0.03 per unit of risk. If you would invest  1,253  in NewAmsterdam Pharma on September 1, 2024 and sell it today you would earn a total of  732.00  from holding NewAmsterdam Pharma or generate 58.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

NewAmsterdam Pharma  vs.  Aldeyra

 Performance 
       Timeline  
NewAmsterdam Pharma 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in NewAmsterdam Pharma are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, NewAmsterdam Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.
Aldeyra 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aldeyra has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

NewAmsterdam Pharma and Aldeyra Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NewAmsterdam Pharma and Aldeyra

The main advantage of trading using opposite NewAmsterdam Pharma and Aldeyra positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Aldeyra can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aldeyra will offset losses from the drop in Aldeyra's long position.
The idea behind NewAmsterdam Pharma and Aldeyra pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments